Machine Learning Helps Predict Postpartum Hemorrhage Risk
Sema4 and Mount Sinai collaborated on two studies that demonstrate how machine learning can be used to improve postpartum hemorrhage risk prediction.
Category: Prenatal Testing
Prenatal Testing
Latest
Prenatal Testing
Latest
Scientists Develop Blood Test to Predict Environmental Harms to Children
The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.
Prenatal Testing
Latest
Novel Biomarker Discovery Could Lead to Early Diagnosis of Preeclampsia
The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.
Study Validates Biomarker for Aneuploidy and Adverse Pregnancy Outcomes
Statisticians used data from more than a million Panorama tests to devise an algorithm that computes a fetal fraction-based risk score for pregnancy.
Read More
August/September Product News
This month’s Product News section features products from Qiagen, ELITechGroup Biomedical Systems, and DiaSorin Molecular.
Read More
Natera Announces New Clinical Utility Data and Issuance of CPT Code for NIPT in Twin Pregnancies
A noninvasive prenatal test for zygosity in twin pregnancies enables obstetricians to triage patients and avoid both overtreatment and undertreatment.
Read More
Qiagen, Natera Partner to Develop NGS Assays
For use on Qiagen’s next-generation sequencing system, the cell-free DNA assays will enable access to genetic testing, including prenatal screening, in hospitals and laboratories globally.
Read MoreIllumina, Harvard Pilgrim Expand Access to Next-Generation Sequencing for NIPT
Illumina has signed a contract with Harvard Pilgrim Health Care to accelerate patient access to next-generation sequencing for noninvasive prenatal testing.
Read More
BD Launches Blood Collection Tube for Cancer, Noninvasive Prenatal Testing Applications
The plastic blood collection tube incorporates a proprietary sample stabilization additive and BD Vacutainer Hemogard technology, and was designed to ensure accurate and reproducible results in molecular diagnostic testing applications using circulating cell-free DNA.
Read More
Natera’s Noninvasive Prenatal Test Now Available for Screening Twin Pregnancies
The Panorama noninvasive prenatal test is now validated to screen twin pregnancies for zygosity and chromosomal abnormalities.
Read More
Test Seeks to Advance Prenatal Screening
A large clinical experience study has evaluated the performance of the Panorama noninvasive prenatal test from Natera Inc.
Read MoreIllumina Debuts Noninvasive Prenatal Testing Software
The updated software includes an innovative method for processing samples and is designed for larger batches of 48 samples, versus the current 16 samples.
Read More
LabCorp Tapped as US Distributor of Preterm Birth Risk Blood Test
The test can help physicians identify women at increased risk for premature delivery as early as 19 weeks into the pregnancy.
Read MoreNoninvasive Prenatal Test Based on Methylation-Specific Quantitative PCR
The test’s associated proprietary software is now cleared for the analysis of data from next-generation sequencing, as well as from qPCR.
Read More
Companies Unveil Integrated Rapid Diagnostic Blood Test for hCG
Delivering accurate results in 5 minutes, the hCG test uses a lateral-flow platform that incorporates an integrated buffer delivery mechanism.
Read More
LabCorp to Acquire Sequenom for $302 Million
The transaction represents a total enterprise value of approximately $371 million, including Sequenom’s net indebtedness.
Read More
Rapid Blood Test Diagnoses Pregnancy at the Point of Care
Results are delivered in 10 minutes.
Read MoreStudy Yields Positive Results for Noninvasive Prenatal Test
In a clinical validation study, Sequenom’s laboratory-developed noninvasive prenatal test was shown to exhibit high resolution, sensitivity, and specificity.
Read More